Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-6-6
pubmed:abstractText
To assess the efficacy of a continuous-combined transdermal patch (estradiol/ norethisterone acetate [E(2)/NETA] 25/125; Estragest TTS, Novartis, Basel, Switzerland) in the reduction of bone loss in postmenopausal women.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1072-3714
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12792297-Administration, Cutaneous, pubmed-meshheading:12792297-Bone Density, pubmed-meshheading:12792297-Bone Remodeling, pubmed-meshheading:12792297-Dose-Response Relationship, Drug, pubmed-meshheading:12792297-Double-Blind Method, pubmed-meshheading:12792297-Drug Combinations, pubmed-meshheading:12792297-Endometrium, pubmed-meshheading:12792297-Estradiol, pubmed-meshheading:12792297-Estrogen Replacement Therapy, pubmed-meshheading:12792297-Female, pubmed-meshheading:12792297-Femur, pubmed-meshheading:12792297-Humans, pubmed-meshheading:12792297-Lumbar Vertebrae, pubmed-meshheading:12792297-Middle Aged, pubmed-meshheading:12792297-Norethindrone, pubmed-meshheading:12792297-Osteoporosis, Postmenopausal, pubmed-meshheading:12792297-Progesterone Congeners, pubmed-meshheading:12792297-Treatment Outcome
pubmed:articleTitle
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
pubmed:affiliation
Bone Metabolic Unit, Scientific Institute, San Raffaele Hospital, Milan, Italy. rubinacci.alessandro@hsr.it
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study